Superoxide dismutase for Skin

Besides An Essential Skin Care Ingredient, Superoxide dismutase Can Do More!

• 2024-07-18
  

  How Does Copper Help Your Body | Detailed Explanation

  Apart from playing its part in the bloodstream, copper becomes a luminous stage center for enzymatic functions. Imagine copper as the behind-the-scenes element that is essential and supports numerous key cellular enzymes. The last act of this journey, that is, the use of matter produced in the first steps issued from hydrogen and oxygen atoms to transfer energy is orchestrated by a mitochondrial enzyme called cytochrome oxidase with a high level of copper. Because copper activates superoxide dismutase, which is an antioxidant enzyme, it protects against free radicals maintaining the health of the cells.
  How does copper help your body
• 2024-04-09
  

  Robertet partners with Aethera to strengthen its active ingredients offering

  Both companies leverage advances in biotechnology to sustainably produce plant-based ingredients. As a pioneer in extracting natural ingredients, Robertet offers a range of active ingredients, including superoxide dismutase SOD B, a powerful antioxidant extracted from a unique variety of melon. This innovation led to the launch of active ingredients Extramel, Dimpless, Holimel and Melorun, each offering benefits in different areas.
  Aethera Biotech Robertet
• 2023-05-04
  

  Two AD new drugs on the market, revenue is negative, Bojian how to recover the loss?

  On April 26, Biogen /lonis jointly announced that the FDA had granted accelerated approval for the antisense oligonucleotide therapy Tofersen for the treatment of patients with amyotrophic lateral sclerosis (ALS) caused by superoxide dismutase 1 (SOD1) mutations. This is the first FDA-approved therapy for hereditary ALS, and it is the first ALS therapy to receive accelerated approval based on a biomarker.
  biogen
• 2022-10-20
  

  When is 'water inverse' going on? Biogen's ALS drug approval delayed to next April

  Tofersen is an antisense oligonucleotide drug developed by Biogen in collaboration with Ionis Pharmaceuticals for the treatment of superoxide dismutase 1 (SOD1) -ALS. Tofersen binds to the mRNA encoding SOD1, allowing it to be degraded by ribonuclease, thereby reducing SOD1 protein production.
  Biogen Tofersen oligonucleotide
• 2022-06-17
  

  End of Cooperation Again! Biogen and Karyopharm Halt ALS Drug Development

  Biogen is currently collaborating with Ionis on a Phase III study of tofersen, an investigational antisense drug targeting superoxide dismutase 1 (SOD1) in patients with amyotrophic lateral sclerosis. Although the drug had previously failed to meet its primary endpoint, the latest data from the two companies' Phase III VALOR trial, which lasted 12 months earlier this month, showed the drug's potential to slow declines in muscle stress, clinical and respiratory function. . In addition, early survival data also suggest that if the drug is given early for treatment, it may reduce the risk of permanent ventilation or death.
  Biogen Karyopharm
• 2022-06-01
  

  An Insight Into The Alzheimer's Breakthrough New Drug

  Elevated levels of free radicals and dysfunction of the antioxidant system may damage brain cells, eventually leading to the occurrence and progression of AD, which in turn promotes the aggregation of Aβ and the phosphorylation of microtubule-related protein tau, aggravating the imbalance of redox reactions in AD brains , and excessive Aβ deposition and tau protein phosphorylation accelerate AD process. Panax notoginseng saponins can increase the activities of total superoxide dismutase, glutathione peroxidase and catalase in the brain of SAMP8 mice and reduce the expression level of 8-hydroxydeoxyguanosine, a DNA damage marker Rat brain tissue is damaged by oxidative stress and activates the Nrf2/HO-1 pathway to reduce oxidative stress damage.
  AD Alzheimer's disease